Antihemophilic factor (recombinant) porcine sequence Intravenous

Uncategorized

Antihemophilic factor (recombinant) porcine sequence Intravenous

What is Antihemophilic factor (recombinant) porcine sequence Intravenous
?

Antihemophilic factor (recombinant) porcine sequence Intravenous is a recombinant form of human antihemophilic factor that is produced in pigs. This medication is used to treat and prevent bleeding in people with hemophilia A. It is a type of clotting factor that helps to form blood clots.

Benefits of Antihemophilic factor (recombinant) porcine sequence Intravenous
and Its Uses.

Antihemophilic factor (recombinant) porcine sequence intravenous is a recombinant, clotting factor VIII replacement therapy indicated for the treatment of hemophilia A. Hemophilia is a rare, inherited bleeding disorder that occurs in males and results from a deficiency or dysfunction of clotting factor VIII. Hemophilia A is the most common form of the disorder, accounting for approximately 80% of all cases. People with hemophilia A experience prolonged or spontaneous bleeding, especially into the joints and muscles.
The U.S. Food and Drug Administration (FDA) approved antihemophilic factor (recombinant) porcine sequence intravenous in September 2017.

Antihemophilic factor (recombinant) porcine sequence intravenous is a recombinant, clotting factor VIII replacement therapy indicated for the treatment of hemophilia A. Hemophilia is a rare, inherited bleeding disorder that occurs in males and results from

Side Effects and Dosage of Antihemophilic factor (recombinant) porcine sequence Intravenous

Antihemophilic factor (recombinant) porcine sequence Intravenous is a recombinant form of porcine factor VIII, which is used to treat and prevent bleeding in people with hemophilia. Hemophilia is a disorder that prevents the blood from clotting properly, which can lead to uncontrolled bleeding.

Antihemophilic factor (recombinant) porcine sequence Intravenous is available as a powder that is reconstituted with sterile water before injection. It is typically given by intravenous injection, but can also be given by subcutaneous or intramuscular injection.

The most common side effects of antihemophilic factor (recombinant) porcine sequence Intravenous include fever, headache, chills, nausea, vomiting, diarrhea, joint pain, and muscle pain.

The recommended dosage of antihemophilic factor (recombinant) porcine

Category: Uncategorized
Posts created 12429

Leave a Reply

Your email address will not be published.

Related Posts

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top